Convano Announces Mid-Term Management Plan Through FY March 2029

Convano Inc. (HQ: Shibuya-ku, Tokyo) has formulated a new mid-term management plan for the period from FY March 2027 to FY March 2029. In addition to growing its flagship "FASTNAIL" business, the company has expanded into healthcare, consulting, and DX/AI/AX promotion. Convano aims to evolve into a "business creation platform" by organically integrating these business segments.

Mid-Term Management Plan Highlights

- Target sales for FY March 2029: 37 billion yen. - Target operating profit for FY March 2029: 13 billion yen. - Target operating profit margin: 35.19%. - Key growth drivers: Nail, healthcare, consulting, and DX/AI segments. - Strategic shift: Transitioning from a "market capitalization-focused" approach to "operating profit and ROE-focused" management. - Objective: To become a corporate group within the top 7% of listed companies in scale.

Background

In recent years, Convano has been restructuring its management base and expanding field-proven insights from its nail business into consulting and healthcare sectors to build new growth foundations.

With rising demand for operational efficiency and service refinement driven by advancements in data usage and AI, the company views this market environment as a significant growth opportunity, prompting the revision of its mid-term plan.

Growth Strategy

Under the concept, "Knowing, Understanding Structures, and Building Systems," Convano will drive three cycles of growth:

1. Knowledge Circulation: Converting field-accumulated insights into formal knowledge and providing them as consulting services. 2. DX/AX Implementation: Solving challenges discovered through consulting using digital technology and AI to drive automation and efficiency. 3. Value Creation & Domain Expansion: Productizing systems and services generated through DX/AI and deploying them into new markets.

Business-Specific Strategies

- Nail Business: Strengthening revenue base through store expansion and productivity improvement centered on the FASTNAIL brand. - Healthcare Business: Enhancing support services and DX solutions for medical institutions, capitalizing on the expanding cosmetic medicine market. - Consulting Business: Expanding management, operations, and DX consulting services using practical know-how cultivated within the group. - DX/AI/AX Business: Implementing accumulated insights as AI/systems for operational improvements and new service development.

Financial Targets

| Fiscal Year | Sales | Operating Profit | Operating Profit Margin | | :--- | :--- | :--- | :--- | | FY March 2027 | 26.7 billion yen | 8.9 billion yen | 33.48% | | FY March 2028 | 30.0 billion yen | 10.3 billion yen | 34.56% | | FY March 2029 | 37.0 billion yen | 13.0 billion yen | 35.19% |

Outlook

Convano aims to evolve into a business creation platform by fusing its core nail business with healthcare and DX/AI domains. Furthermore, by making a full-scale entry into Web3 infrastructure, it seeks to establish itself as a next-generation platformer from Japan.

FACT BOX

  • Source: PR TIMES
  • Category: News
  • Products / services: FASTNAIL